Hat tip to Fern64 from stocktwits

[biopearl123]

https://www.onclive.com/view/imetelstat ... erge-trial

Very nice 10 min discussion. Worth listening all the way to the end for clarity on the “extension” study (QT study) which was a back door in for patients who had also also received HMA’s. The QT part of the study (see previous posts) is a smoke screen. This data has not been presented yet but will almost certainly come out at ASH. I think previous treatment with HMAs may make subsequent treatments less effective.

[rccola335]

Excellent video - luspstercept has uses but is not in the same class as imet